Nomogram construction and validation
A total of 668 patients with stage II-IV CRNENs from the SEER database were randomly divided into a training cohort (n=468) and a validation cohort (n=200) at a ratio of 7:3. Next, the training cohort was used for prognostic analysis and competing risk analysis, the validation cohort and the independent validation cohorts were used for internal and external validation.